• SENSEX 74,828.25
    299.17 (+0.40%)
  • BANKNIFTY 56,548.90
    333.35 (+0.59%)
  • Meesho
    230.80 125.70(%)
  • SS Retail
    766.90 766.90(%)
  • Allied Blenders
    667.75 719.95(%)
  • Escorts Kubota
    2,828.00 3,998.95(%)
  • Molbio Diagnosti
    1,338.00 1,686.50(%)
  • Swiggy
    276.80 235.85(%)
  • Hero Motors
    98.51 98.51(%)
  • Ather Energy
    1,484.00 535.00(%)
  • ICICI Bank
    1,334.00 1,187.55(%)
  • Cupid
    276.25 298.95(%)
  • Kanohar Elect.
    938.00 938.00(%)
  • Ola Electric
    42.50 59.20(%)
  • Glass Wall Syst.
    278.45 185.05(%)
  • HDFC Bank
    734.00 682.00(%)
  • Tour. Fin. Corp.
    143.00 148.00(%)
  • Whirlpool India
    865.35 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,783.85 1,952.00(%)
  • Elecon Engg.Co
    476.90 625.45(%)
  • Reliance Industries
    1,253.05 1,611.20(%)
  • Bluestone Jewel
    823.55 400.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Orchid Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3135.0
  • ISIN : INE191A01027
1,102.05 -5 (-0.47%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    1,090.00

  • Today’s High

    1,129.20

  • Open

    1,105.00

  • Perv Close

    1,107.20

  • 52W Low

    480.00

  • 52W High

    1,143.50

Key Indicators

  • P/E(TTM)

    136.76

  • Mar.Cap (₹Cr.)

    6,599.65

  • Div & Yield %

    0.00

  • Book Value(₹)

    274.97

  • Debt-Equity Ratio

    -0.47

  • AGM Date

    23-Sep-2026

  • EPS

    8.07

  • P/E Ratio

    136.76

Financials Ratios

  • Debt-Equity Ratio

    0.25

  • Mar.Cap (₹Cr.)

    6,599.65

  • RONW (%)

    3.02

  • ROCE (%)

    3.20

Score Board

  • Equity (₹ in Cr.)

    59.89

  • BV (₹)

    275.00

  • Sales( ₹ in Cr.)

    1,232.78

  • NP (in Cr.)

    47.24

  • NP Var(%)

    -68.0

  • Div%

    0.0

  • CPS (₹)

    15.10

  • EPS (₹)

    7.90

  • Traded Value (₹ in Lakhs)

    6,609.23

  • 52 Week High

    1,143.50

  • 52 Week Low

    480.00

  • Price BSE

    1104.0

  • Price NSE

    1,102.00

  • Market Capital( in Cr.)

    6,609.23

  • P/C Ratio

    73.00

  • P/E Ratio

    140.00

  • Price Vs.BV

    7.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,232.78 1,397.61 819.37 665.90 556.97 450.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,232.78 1,397.61 819.37 665.90 556.97 450.70
Other Income 56.49 36.43 30.39 58.64 56.97 6.46
Stock Adjustments -71.38 21.95 43.89 21.48 22.73 15.69
Total Income 1,217.89 1,455.99 893.65 746.02 636.67 472.85
EXPENDITURE :            
Raw Materials 773.08 915.30 528.35 406.10 336.80 244.96
Power and Fuel Cost 89.62 100.07 62.92 61.26 52.74 39.31
Employee Cost 114.32 109.23 69.64 65.35 60.21 64.40
Other Manufacturing Expenses 47.89 51.91 32.65 29.19 26.26 24.26
Selling and Administration Expenses 66.80 73.41 53.17 34.96 37.77 31.58
Miscellaneous Expenses 38.89 18.47 5.46 7.28 7.22 24.38
Employee Benefit Expenses 114.32 109.23 69.64 65.35 60.21 64.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,130.59 1,268.38 752.20 604.14 521.00 428.89
Operating Profit 87.30 187.61 141.45 141.88 115.67 43.96
Interest 9.32 13.25 16.71 32.90 33.46 52.21
Gross Profit 77.98 174.36 124.74 108.98 82.21 -8.25
Depreciation 43.36 41.91 33.22 54.79 87.02 108.90
Profit Before Tax 34.62 132.45 91.52 54.19 -4.81 -117.15
Current Tax 0.00 0.23 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -9.69 -3.23 0.00 0.00 0.00
Reported Net Profit 34.62 141.90 94.75 54.19 -4.81 -117.15
Extraordinary Items -12.62 -5.89 -0.19 40.00 0.51 0.98
Adjusted Net Profit 47.24 147.79 94.94 14.19 -5.32 -118.13
Adjustment below Net Profit 0.00 238.80 0.00 0.00 0.00 0.00
P & L Balance brought forward -1,608.38 -1,988.38 -2,082.68 -2,136.64 -2,133.29 -2,016.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -1.18 0.70 0.45 0.23 -1.46 -0.60
P & L Balance carried down -1,572.58 -1,608.38 -1,988.38 -2,082.68 -2,136.64 -2,133.29
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 22.63 92.75 18.68 13.28 -1.18 -28.70
Earnings Per Share(Adj)-Unit Curr 22.63 92.75 18.68 13.28 -1.18 -28.70
Book Value 1,047.18 1,023.69 226.69 162.53 149.30 150.13
Book Value(Adj)-Unit Curr 1,047.18 1,023.69 226.69 162.53 149.30 150.13

Shareholding Pattern

  • Promoter Group

    69.84%

  • Public Share Holding

    30.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,419,957 69.84 35,419,957 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 35,419,957 69.84 35,419,957 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 32,440 0.06 32,440 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 408,009 0.80 408,009 25
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 2,396 0.00 2,396 1
Insurance Companies 33,877 0.07 33,877 3
Mutual Funds / UTI 10,107,812 19.93 10,107,812 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 347,550 0.69 347,550 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,932,084 21.55 10,932,084 48
2] Non Institution
Bodies Corporate 801,579 1.58 798,341 360
Clearing Members 217 0.00 217 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 228,180 0.45 228,180 611
Foreign Non Institution Other 68 0.00 68 1
Hindu Undivided Families 158,650 0.31 158,650 948
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 509,869 1.01 509,869 16
Individuals holding nominal share capital up to Rs. 1 lakh 2,640,879 5.21 2,640,609 31,440
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 26,987 0.05 26,987 2
Others 635 0.00 635 3
Sub Total 4,367,064 8.61 4,363,556 33,384
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 50,719,105 100.00 50,715,597 33,433

Company Background

Orchid Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Orchid Pharma Ltd
  • BSE Code : 3135.0
  • ISIN : INE191A01027

  • Incorporation Year

    1992

  • Registered Office

    Orchid Towers Nungambakkam
    313 Valluvar Kottam High Road, Chennai,
    Tamil Nadu-600034

  • Telephone

    91-44-28211000/28230000

  • FAX

    91-44-28211002

  • Chairman

    R G Agarwal

  • Managing Director

  • Company Secretary

    Kapil Dayya

  • Auditor

    Singhi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar


    ,
    ,
    Mumbai -

Orchid Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Orchid Pharma 1,103.65 1,289.27 1,232.78 161.12 1.68
Abbott India 26,948.70 7,217.19 6,929.05 35.47 43.78
Astrazeneca Phar 6,709.20 2,304.07 2,275.58 98.88 27.86
Glaxosmi. Pharma 2,876.50 3,932.76 3,790.20 45.95 58.17
Novartis India 2,026.85 393.10 354.33 51.18 15.94
Cipla 1,380.00 20,102.60 18,979.95 36.27 13.88
Bliss GVS Pharma 696.95 773.53 729.81 64.77 12.51
Amrutanjan Healt 509.85 520.13 502.55 27.31 24.16
Fermenta Biotec. 474.15 474.15 450.25 22.14 18.77
Guj. Themis Bio. 410.05 168.25 165.82 109.64 18.05
Ambalal Sarabhai 40.23 19.52 3.94 74.50 6.77